We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$131B
1-Year Est. Return
28.36%
This Fund
S&P 500
This Quarter
Est. Return
+3.72%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$134B
AUM Growth
-$2.51B
(-1.8%)
Cap. Flow
-$4.46B
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
2,213
New
182
Increased
966
Reduced
894
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBCR
Neuberger Core Equity ETF
NBCR
|
+$190M |
| 2 |
United Rentals
URI
|
+$166M |
| 3 |
Constellation Energy
CEG
|
+$147M |
| 4 |
UGI
UGI
|
+$134M |
| 5 |
Celestica
CLS
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$246M |
| 2 |
S&P Global
SPGI
|
+$201M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$197M |
| 4 |
Aon
AON
|
+$184M |
| 5 |
JPMorgan Chase
JPM
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.15% |
| 2 | Financials | 14.23% |
| 3 | Industrials | 11.38% |
| 4 | Healthcare | 9.42% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Clean Energy Fuels
CLNE
$427M
| $26K | ﹤0.01% |
12,378
+1,767
| +17% | +$4.32K |
|
2077
8x8 Inc
EGHT
$269M
| $26K | ﹤0.01% |
+13,178
| New | +$25.9K |
|
2078
Satellogic
SATL
$531M
| $25.2K | ﹤0.01% |
+13,502
| New | +$29.2K |
|
|
FFAI
2079
Faraday Future Intelligent Electric
FFAI
$15.2M
| $23.3K | ﹤0.01% |
+152
| New | +$28.2K |
|
2080
Bit Digital
BTBT
$463M
| $23.3K | ﹤0.01% |
+12,307
| New | +$35.6K |
|
2081
Editas Medicine
EDIT
$396M
| $22.4K | ﹤0.01% |
10,908
-1,089
| -9% | -$3.14K |
|
2082
Alector
ALEC
$168M
| $22.1K | ﹤0.01% |
+14,173
| New | +$25.1K |
|
|
LFT
2083
Lument Finance Trust
LFT
$34.6M
| $22K | ﹤0.01% |
+15,605
| New | +$24.9K |
|
2084
OneMedNet
ONMD
$41M
| $21.5K | ﹤0.01% |
19,504
| – | – |
|
2085
Montauk Renewables
MNTK
$243M
| $20.9K | ﹤0.01% |
12,525
-2,097
| -14% | -$4.03K |
|
2086
Nkarta
NKTX
$150M
| $19K | ﹤0.01% |
+10,279
| New | +$20.5K |
|
2087
TScan Therapeutics
TCRX
$48.6M
| $18.4K | ﹤0.01% |
18,400
| – | – |
|
2088
Coherus Oncology
CHRS
$217M
| $18.4K | ﹤0.01% |
12,951
-4,157
| -24% | -$6.06K |
|
2089
3D Systems Corp
DDD
$431M
| $18.1K | ﹤0.01% |
10,249
-5,930
| -37% | -$14.4K |
|
2090
Sabre
SABR
$731M
| $17.7K | ﹤0.01% |
12,991
-2,560
| -16% | -$4.41K |
|
2091
SkinHealth Systems
SKIN
$88.8M
| $17K | ﹤0.01% |
+12,252
| New | +$17.7K |
|
|
ATYR
2092
aTyr Pharma
ATYR
$47.6M
| $16K | ﹤0.01% |
+20,454
| New | +$16.8K |
|
2093
Fate Therapeutics
FATE
$286M
| $13.7K | ﹤0.01% |
+13,950
| New | +$16.8K |
|
2094
Kosmos Energy
KOS
$1.6B
| $13.5K | ﹤0.01% |
14,887
+798
| +6% | +$1.05K |
|
|
TEAD
2095
Teads Holding Co
TEAD
$68.7M
| $11.4K | ﹤0.01% |
+16,175
| New | +$17.1K |
|
2096
Myomo
MYO
$39M
| $10.1K | ﹤0.01% |
+11,136
| New | +$10.7K |
|
2097
Agilon Health
AGL
$1.53B
| $8.95K | ﹤0.01% |
520
+34
| +7% | +$659 |
|
2098
PLAYSTUDIOS Inc
MYPS
$77.9M
| $8.04K | ﹤0.01% |
12,346
+887
| +8% | +$691 |
|
2099
Enlivex Ltd
ENLV
$35.2M
| $7.73K | ﹤0.01% |
733
| – | – |
|
2100
Tevogen Inc. Common Stock
TVGN
$29.7M
| $4.76K | ﹤0.01% |
+288
| New | +$7.49K |
|
Similar funds
Neuberger Berman Group's Q4 2025 Portfolio in Review
As of Q4 2025, Neuberger Berman Group held 2,213 positions worth $134B, down 1.8% from $137B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Neuberger Berman Group withdrew a net $4.46B in Q4 2025, closing 102 positions and reducing 894 holdings. Its most notable exit was Verona Pharma, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Neuberger Berman Group opened a new position in BillionToOne Inc worth $57.4M.
- Neuberger Berman Group's largest Q4 2025 buy was BillionToOne Inc: 700,867 shares worth $57.4M.
- Neuberger Berman Group added most to Neuberger Core Equity ETF in Q4 2025, an estimated $190M increase.
- Neuberger Berman Group's biggest Q4 2025 reduction was Sandisk, cutting an estimated $246M.
- Neuberger Berman Group fully exited Verona Pharma in Q4 2025, selling an estimated $36M.
- Neuberger Berman Group's ten largest holdings make up 24% of its $134B portfolio in Q4 2025.
- Neuberger Berman Group opened 182 new positions and closed 102 in Q4 2025.
- Neuberger Berman Group's portfolio value fell 1.8% quarter-over-quarter to $134B.
Based on Neuberger Berman Group's 13F filing for Q4 2025, filed 13 Feb 2026.